患有喘的儿童唾液的免疫状态 根据疾病严重程度
Svitlana Leshchuk1, Zaki Hakami2, Satish Vishwanathaiah3
1Department of Pediatric Dentistry, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
International journal of clinical pediatric dentistry
|November 10, 2025
概括
患有喘的儿童的唾液免疫防御能力降低,包括较低的分泌免疫球蛋白A (sIgA) 和酶水平. 这可能会增加他们患牙的风险.
科学领域:
- 儿科牙科 儿科牙科
- 免疫学 免疫学 免疫学
- 口腔健康 口腔健康
背景情况:
- 喘是一种慢性呼吸道疾病,影响全球儿童.
- 喘儿童免疫状况的改变可能会影响口腔健康.
- 唾液免疫因子在维持口腔防御方面发挥着至关重要的作用.
研究的目的:
- 评估患有喘的儿童的唾液免疫状况.
- 为了将免疫标记与喘严重程度和持续时间相关联.
- 评估喘儿童口腔中的局部免疫水平.
主要方法:
- 从98名喘儿童和68名健康对照组中采集了唾液样本.
- 评估免疫球蛋白A (IgA),免疫球蛋白G (IgG),分泌免疫球蛋白A (sIgA) 和酶活性的水平.
- 放射性免疫扩散方法用于确定IgA和IgG度.
主要成果:
- 与对照组相比,喘儿童的sIgA (2.0x),IgA (1.6x) 和lyszyme (2.2x) 水平显著降低.
- 在喘儿童中观察到IgG水平 (1.2x) 略有增加.
- 根据喘的严重程度和持续时间来评估免疫标志物水平.
结论:
- 患有喘的儿童表现出唾液免疫防御机制受损.
- 喘儿童的唾液免疫力降低可能是导致脏病发病率增加的一个因素.
- 需要进一步的研究来探索喘,唾液免疫和牙健康之间的联系.
相关概念视频
Asthma-III: Symptoms and Complications
3.2K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K


